ridethepig | Coronavirus Retrace LegThe underlying USD devaluation seems little changed on the whole despite the Coronavirus hijack. Volatility is subdued as seen in the diagram below, which is making it very simple for large sizings to enter as was the case in 2007.
The USD weakness (which is a lot clearer on the Monthly chart) is a significant component in the reflation trade, growth projections in the US (in terms of GDP) are slowing and this remains ongoing despite Kudlow et al on the wires. The path of least resistance for Powell is to cut, while the Yield curve (below) shows the recession risks are still there and prevalent.
The titanic takes a long time to turn around, I am sitting tight in the Dollar sell-side for the mid and long term. You can see the picture clearly here that the 2017 highs are holding:
...my forecast is for a gradual decline in the next Q before significantly weakening towards the back-end in the year.
Don't forget to keep the likes and comments coming! Thanks!
Ncov
ridethepig | GILD 2019-nCoV TargetA good time to review the previous floor at 60.xx that we have been tracking for almost a year in $GILD. Here taking the latest misses in Q4 Earnings with a pinch of salt as the red carpet has been rolled out for Gild via China. Once again another buying opportunity given the latest progress around Phase III clinical trials:
On the Remdesivir (GS-5734) side, this is their free pass into the Chinese Healthcare system. Models will need to start quickly repricing revenue from the Hep B cases in China. GILD will do the heavy lifting here, +/- $20 upside available on the headline for FDA approval which looks around the corner. Flow-wise, the initial target area from the latest technical break comes into play at 86.xx (+25% from current levels).
As usual thanks for keeping the support coming with likes, comments and etc!